NovoCure Limited (NVCR) Financials

NVCR Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 787.9 million 457.2 million
Dec. 31, 2025 804.3 million 463.9 million
Sept. 30, 2025 1.4 billion 1.0 billion
June 30, 2025 1.2 billion 896.4 million

NVCR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -18.7 million 63.0 million
Dec. 31, 2025 -22.9 million 19.8 million
Sept. 30, 2025 14.9 million 29.3 million
June 30, 2025 -21.4 million 26.1 million

NVCR Net Income

No data available :(

NVCR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 441.8 million 195.5 million 39.5 million
Dec. 31, 2025 457.5 million 236.7 million 41.6 million
Sept. 30, 2025 1.0 billion 194.6 million 42.7 million
June 30, 2025 911.5 million 97.6 million 42.9 million

NVCR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 114.1 million
Dec. 31, 2025 111.5 million
Sept. 30, 2025 111.9 million
June 30, 2025 111.6 million

NVCR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 5.2 million 58.3 million 144.2 million -
Dec. 31, 2025 4.9 million 60.9 million 111.7 million 68.7 million
Sept. 30, 2025 5.7 million 54.0 million 104.5 million 58.5 million
June 30, 2025 5.5 million 55.8 million 101.0 million 57.1 million

NVCR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 174.1 million 38.9 million
Dec. 31, 2025 174.4 million 42.2 million
Sept. 30, 2025 167.2 million 44.7 million
June 30, 2025 158.8 million 41.5 million

NVCR

Price: $16.15

52 week price:
9.82
20.06

Earnings Per Share: -1.53 USD

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Country: Jersey

Volume: 542600

Ebitda: -3.9 million

Market Capitalization: 2.0 billion

Links: